Fig. 2From: Effectiveness of 8-week TReatment with vortioxetine on depressive symptoms in major depressive disorder patients with comorbid generalized anxiety disorder in UAE (TRUE)Change in mean MADRS scores from baseline to 2, 4, and 8 weeksBack to article page